As announced on 7 April and 10 June 2016, the Board of East Capital Explorer AB (publ) has resolved to carry out a share buyback program for as long as the Company’s shares trade at a discount of more than 20 percent to its most recently published NAV in SEK. The Board’s repurchase decision falls within the scope of the authorization given to the Board by the Annual General Meeting 2016. The purpose of the buyback program is to reduce the share capital of East Capital Explorer. Execution is dependent upon market terms, applicable rules and regulations and the Company’s capital position at each point in time. East Capital Explorer has so far repurchased 2,095,745 of its own shares for SEK 132m under this program, corresponding to 7.4 percent of the Company’s outstanding shares. The total number of shares in East Capital Explorer amounts to 28,161,563. Over the coming period from 11 October until 31 December 2016, East Capital Explorer’s repurchase program will be conducted in accordance with the safe harbor provisions in the Regulation (596/2014/EU) of the European Parliament and of the Council on market abuse, and in the Commission Delegated Regulation (EU) 2016/1052 (“MAR”), which means that the repurchases are managed by a financial institution that makes discretionary trading decisions[1] (http://#_ftn1) with the following restrictions: - Repurchases of shares are to be made on Nasdaq Stockholm in accordance with the rules regarding purchase of a Company’s own shares as set out in Nasdaq Stockholm’s Rule Book for Issuers, and in accordance with MAR’s safe harbor provisions. - Repurchases of shares shall be made at a per-share price within the registered price interval at any given time, which denotes the interval between the highest bid and the lowest ask price. - A maximum of 720,411 shares may be repurchased during the period 11 October until 31 December 2016. The Company’s holding of its own shares may not at any time exceed 10 percent of all shares in the Company. - Repurchases for a maximum of SEK 28m may be made during the period. - Repurchases may not be made at a price higher than that which corresponds to 80% of the Company’s latest published NAV per share. - Payment for the shares is to be made in cash. The Board of Directors intends to propose to reduce the share capital in the Company by cancelling the shares repurchased under this program at an EGM, or no later than at the 2017 Annual General Meeting. Contact information Mia Jurke, CEO, East Capital Explorer, +46 8 505 885 32 Lena Krauss, CFO and Head of Investor Relations, East Capital Explorer, +46 73 988 44 66 About East Capital Explorer East Capital Explorer AB (publ) is a Swedish investment company, offering unique investment opportunities in Eastern Europe, where the Baltic countries represent the company’s largest investment region. The company primarily invests in unlisted assets within the private equity and real estate segments. East Capital Explorer’s main investment theme is domestic growth and the company targets fast growing sectors such as Retail and Consumer goods, Financials and Real Estate. East Capital Explorer is listed on Nasdaq Stockholm, Mid Cap. Listing: Nasdaq Stockholm, Mid Cap - Ticker: ECEX - ISIN: SE0002158568 - Reuters: ECEX.ST - Bloomberg: ECEX SS Equity This information is information that East Capital Explorer AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 14:00 p.m. CET on 10 October 2016. ---------------------------------------------------------------------- [1] (http://#_ftnref1) The discretionary mandate means that a financial institution can, on behalf of the Company, repurchase shares also during closed periods in connection with financial reports or if the Company at the time of repurchase has insider information.
East Capital Explorer (ECEX): New buyback mandate 11
Top 10 Most Recent News Articles
Voter Events by Valley Community Healthcare Aim to Empower
Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....
Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang
They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...
Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest
A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...
Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring
Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...
Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors
Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...
Continue Reading
Hyliion Class Action Deadline Nears for Investors
Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...
Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil
Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...
Continue ReadingTop 5 Most Recently Viewed Articles
Zepp Health Corp Posts Mixed Q3 Results Amid Product Launches
Financial Overview of Zepp Health Corporation's Third Quarter Zepp Health Corporation (NYSE: ZEPP) recently released its unaudited financial results for the third quarter. The company's revenues totaled $42.5 million with a basic and diluted net loss per share recorded at $0.05, translating to a net loss of $13.3 million. Notably, these figures reflect a challenge the...
Continue Reading
Artea Bank to Ignite Third Fund for Apartment Building Renovation
Artea Bank Launches New Fund for Multi-Apartment Building Renovations AB Artea Bankas has announced its intention to establish a third fund aimed at modernizing multi-apartment buildings. This initiative follows a notification from the European Investment Bank (EIB), signaling the start of negotiations for this new venture. Projected assets for the fund are substantial,...
Continue Reading
Insights on PROCEPT BioRobotics Quarterly Earnings Forecast
Expected Earnings Report for PROCEPT BioRobotics PROCEPT BioRobotics (NASDAQ: PRCT) has set the stage for its next quarterly earnings report, which is eagerly anticipated by investors. The earnings release is scheduled for an upcoming Monday, an event that this company looks forward to with optimism. Market analysts currently predict that PROCEPT BioRobotics will post an...
Continue Reading
Akebia Therapeutics' New Stock Offering Aims for Growth
Akebia Unveils New Public Offering of Common Stock Akebia Therapeutics, Inc. (Nasdaq: AKBA), a dedicated biopharmaceutical company focused on improving the lives of individuals affected by kidney disease, has publicly announced the pricing details of its recent offering. This offering involves 25 million shares of common stock, each priced at $2.00, aiming to generate...
Continue Reading
Crédit Agricole SA Announces Adjustment in Liquidity Contract
Crédit Agricole SA Adjusts Liquidity Contract with Kepler Cheuvreux In a significant move, Crédit Agricole S.A. has announced a reduction of resources available for its liquidity contract with Kepler Cheuvreux. This shift aims to enhance the market activity surrounding the shares of the company, providing better stability and trading conditions in the financial market....
Continue Reading